The role of surgery for high-risk prostate cancer

被引：0
|
作者：
Ucer, Oktay [1 ]
Muezzinoglu, Talha [1 ]
机构：
[1] Celal Bayar Univ, Tip Fak, Urol Anabilim Dali, Manisa, Turkey
来源：
UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY | 2014年 / 13卷 / 01期
关键词：
high-risk prostate cancer; radical prostatectomy; prostate cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Because of PSA screening, urologists can detect clinically localized prostate cancer in patients before the disease has progressed to advanced stages. Nevertheless, some patients are still diagnosed with high-risk prostate cancer. Surgery for high-risk prostate cancer is applied frequently nowadays. Nevertheless, this approach is still surrounded by many controversies. In some high-risk prostate cancer patients, surgery is a one-step modality in treatment and has an excellent oncological prognosis. However, because of the lack of evidence and well-controlled comparative prospective studies, the best course of treatment can be unclear, and oncological outcomes often appear heterogeneous. The aim of this review is to discuss the role of surgery in high risk prostate cancer.
引用
收藏
页码：21 / 24
页数：4
相关论文
共 50 条
  • [41] High-Risk Prostate Cancer: Role of Radical Prostatectomy and Radiation Therapy
    Qi, Robert
    Moul, Judd
    ONCOLOGY RESEARCH AND TREATMENT, 2015, 38 (12) : 639 - 644
  • [42] High-risk prostate cancer: the role of radical prostatectomy for local therapy
    Ghavamian, Reza
    Williams, Steve K.
    Hakimi, A. Ari
    FUTURE ONCOLOGY, 2011, 7 (04) : 543 - 550
  • [43] The role of intravenous zoledronic acid in the management of high-risk prostate cancer
    Gilbert, SM
    Olsson, CA
    Benson, MC
    McKiernan, JM
    CURRENT OPINION IN UROLOGY, 2003, 13 (02) : 133 - 135
  • [44] The Role of Surgery in High-risk Neuroblastoma
    Ryan, Anne L.
    Akinkuotu, Adesola
    Pierro, Agostino
    Morgenstern, Daniel A.
    Irwin, Meredith S.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2020, 42 (01) : 1 - 7
  • [45] High-risk prostate cancer: How high is high?
    Sandler, HM
    CANCER JOURNAL, 2002, 8 (04): : 301 - 302
  • [46] ARNEO: neoadjuvant degarelix + apalutamide before surgery for high-risk prostate cancer
    Fenner A.
    Nature Reviews Urology, 2022, 19 (11) : 634 - 634
  • [47] Additional therapy for high-risk prostate cancer treated with surgery: what is the evidence?
    Morgan, Scott C.
    Dearnaley, David P.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (07) : 939 - 951
  • [48] A systematic review of nerve-sparing surgery for high-risk prostate cancer
    Morozov, Andrey
    Barret, Eric
    Veneziano, Domenico
    Grigoryan, Vagarshak
    Salomon, Georg
    Fokin, Igor
    Taratkin, Mark
    Poddubskaya, Elena
    Gomez Rivas, Juan
    Puliatti, Stefano
    Okhunov, Zhamshid
    Cacciamani, Giovanni E.
    Checcucci, Enrico
    Marenco Jimenez, Jose L.
    Enikeev, Dmitry
    MINERVA UROLOGY AND NEPHROLOGY, 2021, 73 (03): : 283 - 291
  • [49] Surgery Remains an Integral Part of Multimodal Treatment for High-risk Prostate Cancer
    Heidenreich, Axel
    EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (05): : 969 - 970
  • [50] The emerging role of prostate-specific membrane antigen (PSMA) PET-CT in patients with high-risk prostate cancer: moving the bar in high-risk prostate cancer
    Aragon-Ching, Jeanny B.
    ASIAN JOURNAL OF ANDROLOGY, 2021, 23 (01) : 1 - 2
12345